127 related articles for article (PubMed ID: 2155679)
1. ABC of transfusion. Haemolytic disease of the newborn and its prevention.
Tovey LA
BMJ; 1990 Feb; 300(6720):313-6. PubMed ID: 2155679
[No Abstract] [Full Text] [Related]
2. Haemolytic disease of the newborn.
Whitfield CR; Lee D
BMJ; 1990 Mar; 300(6727):814. PubMed ID: 2157515
[No Abstract] [Full Text] [Related]
3. The use of Rh immune globulin: a review.
Sutton GP; Jay A; Lim YS; Noland JE; Boral LI
Indiana Med; 1988 Apr; 81(4):321-2. PubMed ID: 2834434
[No Abstract] [Full Text] [Related]
4. [Comparative analysis of the effects to date of the prevention of Rh incompatibility].
Jedwabny A; Suchocki S; Bobrowska G
Acta Haematol Pol; 1988; 19(1-2):56-8. PubMed ID: 2853507
[No Abstract] [Full Text] [Related]
5. Prevention of haemolytic disease of the newborn due to anti-D.
Tovey G; Wagstaff W
Br Med J (Clin Res Ed); 1981 Jul; 283(6284):142. PubMed ID: 6266575
[No Abstract] [Full Text] [Related]
6. Rho(D) immune globulin. When to use it in the Rho(D)-negative woman.
Lavery JP
Postgrad Med; 1984 Mar; 75(4):259-64. PubMed ID: 6322145
[No Abstract] [Full Text] [Related]
7. Rho (d) immune globulin (human).
Med Lett Drugs Ther; 1974 Jan; 16(1):3-4. PubMed ID: 4202567
[No Abstract] [Full Text] [Related]
8. [Intravenous anti-D immunoglobulins. (Prevention of anti-Rh immunization in France)].
Jouvenceaux A
Pathologica; 1972; 64(929):91-9. PubMed ID: 4210233
[No Abstract] [Full Text] [Related]
9. The prevention of Rh haemolytic disease of the fetus and newborn--general background.
Contreras M
Br J Obstet Gynaecol; 1998 Nov; 105 Suppl 18():7-10. PubMed ID: 9863972
[No Abstract] [Full Text] [Related]
10. Decline in deaths from rhesus haemolytic disease of the newborn.
Clarke C; Hussey RM
J R Coll Physicians Lond; 1994; 28(4):310-1. PubMed ID: 7965968
[TBL] [Abstract][Full Text] [Related]
11. Rh(D) haemolytic disease of the newborn: the changing scene.
Urbaniak SJ
Br Med J (Clin Res Ed); 1985 Jul; 291(6487):4-6. PubMed ID: 2990630
[No Abstract] [Full Text] [Related]
12. Rhesus haemolytic disease.
Whittle MJ
Arch Dis Child; 1992 Jan; 67(1 Spec No):65-8. PubMed ID: 1536591
[No Abstract] [Full Text] [Related]
13. Efforts should be made to eradicate Rh hemolytic disease of the fetus and newborn.
Caiola G
Obstet Gynecol Surv; 1984 Jan; 39(1):55-7. PubMed ID: 6320075
[No Abstract] [Full Text] [Related]
14. Massive feto-maternal haemorrhage: effect of passively administered anti-D in the prevention of Rh sensitization and haemolytic disease of the newborn.
Mills L; Napier JA
Br J Obstet Gynaecol; 1988 Oct; 95(10):1007-12. PubMed ID: 2847774
[TBL] [Abstract][Full Text] [Related]
15. [New recommendations for the completion of rhesus-immunization prophylaxis with anti-D].
Maas DH; Schneider J
Immun Infekt; 1982 Nov; 10(6):244-9. PubMed ID: 6307863
[TBL] [Abstract][Full Text] [Related]
16. [Prevention of Rh-sensitization in primiparas by means of human anti-rhesus-Rho (D) immunoglobulin].
Verbitskiĭ MSh; Bashlaĭ AG; Morgulis NB
Vopr Okhr Materin Det; 1978 Jan; 23(1):27-8. PubMed ID: 415432
[No Abstract] [Full Text] [Related]
17. [Current viewpoints in the anti-D prevention of rhesus alloimmunization in the pregnant woman and of hemolytic disease of the newborn infant (a review of the literature)].
Spasova K; Vŭlcheva B
Akush Ginekol (Sofiia); 1986; 25(3):84-90. PubMed ID: 3019168
[No Abstract] [Full Text] [Related]
18. Antenatal anti-D immunoglobulin.
Lancet; 1983 Sep; 2(8352):734. PubMed ID: 6136859
[No Abstract] [Full Text] [Related]
19. Consensus Conference on Anti-D Prophylaxis. Edinburgh, United Kingdom, 8-9 April 1997. Papers and abstracts.
Br J Obstet Gynaecol; 1998 Nov; 105 Suppl 18():iv, 1-44. PubMed ID: 10328662
[No Abstract] [Full Text] [Related]
20. Controversies in Rh prophylaxis.
Hensleigh PA
Am J Obstet Gynecol; 1985 Sep; 153(1):112-3. PubMed ID: 2994476
[No Abstract] [Full Text] [Related]
[Next] [New Search]
